TIANJIN DEV: Notification Letter to Non-registered Shareholders and Request Form
TIANJIN DEV: Notification Letter to Existing Shareholders and Request Form
TIANJIN DEV: Notice of Annual General Meeting
TIANJIN DEV: Form of Proxy for Annual General Meeting to be held on 19 June 2025
TIANJIN DEV: General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors and Notice of Annual General Meeting
TIANJIN DEV: Annual Report 2024
TIANJIN DEV: Unaudited Financial Results for the three months ended 31 March 2025 of Tianjin Lisheng Pharmaceutical Co., Ltd.
TIANJIN DEV: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025
TIANJIN DEV: Final Dividend for the year ended 31 December 2024
TIANJIN DEV: Announcement of Final Results for the year ended 31 December 2024
TIANJIN DEV: Audited Financial Results for the year ended 31 December 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.
TIANJIN DEV: Date of Board Meeting
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
TIANJIN DEV: Completion of Share Repurchases and Adoption of Share Award Scheme by a Listed Subsidiary
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025
TIANJIN DEV: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024
TIANJIN DEV: List of Directors and their Roles and Functions
TIANJIN DEV: Appointment of Executive Director
TIANJIN DEV: Poll Results of the Extraordinary General Meeting held on 30 December 2024